메뉴 건너뛰기




Volumn 30, Issue 4 SUPPL.73, 2012, Pages

Interest of modelling in rheumatoid arthritis

Author keywords

Modelling; QALY; Rheumatoid arthritis

Indexed keywords

ARTICLE; ARTIFICIAL NEURAL NETWORK; DECISION TREE; MODEL; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; RHEUMATOID ARTHRITIS;

EID: 84870266436     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (26)
  • 1
    • 79955069103 scopus 로고    scopus 로고
    • Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management
    • SUTER LG, FRAENKEL L, BRAITHWAITE RS: Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management. Arch Intern Med 2011;171:657-67.
    • (2011) Arch Intern Med , vol.171 , pp. 657-667
    • Suter, L.G.1    Fraenkel, L.2    Braithwaite, R.S.3
  • 2
    • 23644456726 scopus 로고    scopus 로고
    • An evaluation of the decision tree format of the american college of rheumatology 1987 classification criteria for rheumatoid arthritis: Performance over five years in a primary care-based prospective study
    • LUNT M, SYMMONS DP, SILMAN AJ: An evaluation of the decision tree format of the american college of rheumatology 1987 classification criteria for rheumatoid arthritis: Performance over five years in a primary care-based prospective study. Arthritis Rheum 2005;52:2277-83.
    • (2005) Arthritis Rheum , vol.52 , pp. 2277-2283
    • Lunt, M.1    Symmons, D.P.2    Silman, A.J.3
  • 3
    • 79952471147 scopus 로고    scopus 로고
    • Cost-utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting
    • HALLINEN TA, SOINI EJ, EKLUND K, PUOLAKKA K: Cost-utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting. Rheumatology (Oxford) 2010;49:767-77.
    • (2010) Rheumatology (Oxford) , vol.49 , pp. 767-777
    • Hallinen, T.A.1    Soini, E.J.2    Eklund, K.3    Puolakka, K.4
  • 4
    • 79959436349 scopus 로고    scopus 로고
    • Treatment strategies aiming at remission in early rheumatoid arthritis patients: Starting with methotrexate monotherapy is cost-effective
    • SCHIPPER LG, KIEVIT W, DEN BROEDER AA et al.: Treatment strategies aiming at remission in early rheumatoid arthritis patients: Starting with methotrexate monotherapy is cost-effective. Rheumatology (Oxford) 2011;50:1320-30.
    • (2011) Rheumatology (Oxford) , vol.50 , pp. 1320-1330
    • Schipper, L.G.1    Kievit, W.2    Den Broeder, A.A.3
  • 5
    • 61549117187 scopus 로고    scopus 로고
    • Cost-effectiveness modeling of abatacept versus other biologic agents in dmards and anti-tnf inadequate responders for the management of moderate to severe rheumatoid arthritis
    • RUSSELL A, BERESNIAK A, BESSETTE L et al.: Cost-effectiveness modeling of abatacept versus other biologic agents in dmards and anti-tnf inadequate responders for the management of moderate to severe rheumatoid arthritis. Clin Rheumatol 2009;28:403-12
    • (2009) Clin Rheumatol , vol.28 , pp. 403-412
    • Russell, A.1    Beresniak, A.2    Bessette, L.3
  • 6
    • 79952396885 scopus 로고    scopus 로고
    • Cost-effectiveness modelling of biological treatment sequences in moderate to severe rheumatoid arthritis in france
    • SARAUX A, GOSSEC L, GOUPILLE P et al.: Cost-effectiveness modelling of biological treatment sequences in moderate to severe rheumatoid arthritis in france. Rheumatology (Oxford) 2010;49:733-40.
    • (2010) Rheumatology (Oxford) , vol.49 , pp. 733-740
    • Saraux, A.1    Gossec, L.2    Goupille, P.3
  • 7
    • 80055081129 scopus 로고    scopus 로고
    • Assessing the cost-effectiveness of biologic agents for the management of moderate-to-severe rheumatoid arthritis in anti-TNF inadequate responders in italy: A modelling approach
    • CIMMINO MA, LEARDINI G, SALAFFI F et al.: Assessing the cost-effectiveness of biologic agents for the management of moderate-to-severe rheumatoid arthritis in anti-TNF inadequate responders in italy: A modelling approach. Clin Exp Rheumatol 2011;29:633-41
    • (2011) Clin Exp Rheumatol , vol.29 , pp. 633-641
    • Cimmino, M.A.1    Leardini, G.2    Salaffi, F.3
  • 8
    • 84856153028 scopus 로고    scopus 로고
    • Modelling cost-effectiveness of biologic treatments based on disease activity scores for the management of rheumatoid arthritis in Spain
    • BERESNIAK A, ARIZA-ARIZA R, GARCIA-LLORENTE JF, RAMIREZ-ARELLANO A, DUPONT D: Modelling cost-effectiveness of biologic treatments based on disease activity scores for the management of rheumatoid arthritis in Spain. Int J Inflam 2011;2011:727634.
    • (2011) Int J Inflam , vol.2011 , pp. 727634
    • Beresniak, A.1    Ariza-Ariza, R.2    Garcia-Llorente, J.F.3    Ramirez-Arellano, A.4    Dupont, D.5
  • 9
    • 84860681286 scopus 로고    scopus 로고
    • Cost-effectiveness modelling of sequential biologic strategies for the treatment of moderate to severe rheumatoid arthritis in finland
    • PUOLAKKA K, BLÅFIELD H, KAUPPI M et al.: Cost-effectiveness modelling of sequential biologic strategies for the treatment of moderate to severe rheumatoid arthritis in finland. Open Rheumatol J 2012;6:38-43.
    • (2012) Open Rheumatol J , vol.6 , pp. 38-43
    • Puolakka, K.1    Blåfield, H.2    Kauppi, M.3
  • 10
    • 84855451722 scopus 로고    scopus 로고
    • International cohort study of 73 antiku-positive patients: Association of p70/p80 anti-ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis
    • LAKOTA K, THALLINGER GG, SODIN-SEMRL S et al.: International cohort study of 73 antiku-positive patients: Association of p70/p80 anti-ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis. Arthritis Res Ther 2012;14:R2.
    • (2012) Arthritis Res Ther , vol.14
    • Lakota, K.1    Thallinger, G.G.2    Sodin-Semrl, S.3
  • 11
    • 0142135697 scopus 로고    scopus 로고
    • Direct medical costs and their predictors in patients with rheumatoid arthritis: A threeyear study of 7, 527 patients
    • MICHAUD K, MESSER J, CHOI HK, WOLFE F: Direct medical costs and their predictors in patients with rheumatoid arthritis: A threeyear study of 7, 527 patients. Arthritis Rheum 2003;48:2750-62.
    • (2003) Arthritis Rheum , vol.48 , pp. 2750-2762
    • Michaud, K.1    Messer, J.2    Choi, H.K.3    Wolfe, F.4
  • 12
    • 0023881198 scopus 로고
    • The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis
    • MITCHELL JM, BURKHAUSER RV, PINCUS T: The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis. Arthritis Rheum 1988;31:348-57.
    • (1988) Arthritis Rheum , vol.31 , pp. 348-357
    • Mitchell, J.M.1    Burkhauser, R.V.2    Pincus, T.3
  • 13
    • 84862165188 scopus 로고    scopus 로고
    • Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: An application of bayesian methods for evidence synthesis in a markov model
    • NGUYEN CM, BOUNTHAVONG M, MENDES MA et al.: Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: An application of bayesian methods for evidence synthesis in a markov model. Pharmacoeconomics 2012;30:575-93.
    • (2012) Pharmacoeconomics , vol.30 , pp. 575-593
    • Nguyen, C.M.1    Bounthavong, M.2    Mendes, M.A.3
  • 14
    • 84860333083 scopus 로고    scopus 로고
    • Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis
    • STAHL EA, WEGMANN D, TRYNKA G et al.: Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet 2012;44:483-9.
    • (2012) Nat Genet , vol.44 , pp. 483-489
    • Stahl, E.A.1    Wegmann, D.2    Trynka, G.3
  • 15
    • 77956386199 scopus 로고    scopus 로고
    • Clustering rash results: A novel method for developing rheumatoid arthritis states for use in valuation studies
    • MCTAGGART-COWAN HM, BRAZIER JE, TSUCHIYA A: Clustering rash results: A novel method for developing rheumatoid arthritis states for use in valuation studies. Value Health 2010;13:787-95.
    • (2010) Value Health , vol.13 , pp. 787-795
    • McTaggart-Cowan, H.M.1    Brazier, J.E.2    Tsuchiya, A.3
  • 16
    • 69849101948 scopus 로고    scopus 로고
    • Introduction to neural networks in health care
    • Harvard
    • SORDO M: Introduction to neural networks in health care. Open Clinical 2002; Harvard: 1-17.
    • (2002) Open Clinical , pp. 1-17
    • Sordo, M.1
  • 17
    • 34748898307 scopus 로고    scopus 로고
    • Developing a neural network model for health care
    • NOLTING J: Developing a neural network model for health care. AMIA Annu Symp Proc 2006:1049.
    • (2006) AMIA Annu Symp Proc , pp. 1049
    • Nolting, J.1
  • 18
    • 33846524203 scopus 로고    scopus 로고
    • Predictive role of diagnostic information in treatment efficacy of rheumatoid arthritis based on neural network model analysis
    • ZHA QL, HE YT, YAN XP et al.: Predictive role of diagnostic information in treatment efficacy of rheumatoid arthritis based on neural network model analysis. Zhong Xi Yi Jie He Xue Bao 2007;5:32-8.
    • (2007) Zhong Xi Yi Jie He Xue Bao , vol.5 , pp. 32-38
    • Zha, Q.L.1    He, Y.T.2    Yan, X.P.3
  • 19
    • 1542647357 scopus 로고    scopus 로고
    • Neural network approach to medical grading of rheumatoid arthritis
    • ZHOU Z, MAO Z, DENG Z: Neural network approach to medical grading of rheumatoid arthritis. Sheng Wu Yi Xue Gong Cheng Xue ZaZhi 1999;16:479-82.
    • (1999) Sheng Wu Yi Xue Gong Cheng Xue ZaZhi , vol.16 , pp. 479-482
    • Zhou, Z.1    Mao, Z.2    Deng, Z.3
  • 20
    • 33749355349 scopus 로고    scopus 로고
    • Qalys: Are they helpful to decision makers?
    • MC GREGOR M, CARO JJ: Qalys: Are they helpful to decision makers? Pharmacoeconomics 2006;24:947-52.
    • (2006) Pharmacoeconomics , vol.24 , pp. 947-952
    • McGregor, M.1    Caro, J.J.2
  • 22
    • 79956064523 scopus 로고    scopus 로고
    • Is there an international backlash against cost-utility analysis?
    • RAMSEY S: Is there an international backlash against cost-utility analysis? ISPOR Connections 2010;16:3.
    • (2010) ISPOR Connections , vol.16 , pp. 3
    • Ramsey, S.1
  • 24
    • 84858124911 scopus 로고    scopus 로고
    • Cost-effectiveness of adalimumab, etanercept, and tocilizumab as first-line treatments for moderateto-severe rheumatoid arthritis
    • SOINI EJ, HALLINEN TA, PUOLAKKA K, VIHERVAARA V, KAUPPI MJ: Cost-effectiveness of adalimumab, etanercept, and tocilizumab as first-line treatments for moderateto-severe rheumatoid arthritis. J Med Econ 2012;15:340-51.
    • (2012) J Med Econ , vol.15 , pp. 340-351
    • Soini, E.J.1    Hallinen, T.A.2    Puolakka, K.3    Vihervaara, V.4    Kauppi, M.J.5
  • 26
    • 79961125179 scopus 로고    scopus 로고
    • Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis
    • TOSH JC, WAILOO AJ, SCOTT DL, DEIGHTON CM: Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis. J Rheumatol 2011;38:1593-600.
    • (2011) J Rheumatol , vol.38 , pp. 1593-1600
    • Tosh, J.C.1    Wailoo, A.J.2    Scott, D.L.3    Deighton, C.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.